NORTH SHORE EQUITY ROTATION (KOOL) Stock News
NYSEARCA:KOOL - NYSE Arca - US84858T8559 - ETF - Currency: USD
KOOL Latest News, Press Relases and Analysis
China’s Soul, Keep Eye Shifting U.S. IPOs to Hong Kong
The startups behind Chinese social networking platform Soul and home workout trainer Keep are the latest to join a slew of companies weighing Hong Kong initial public offerings after suspending plans for U.S. listings, according to people familiar with the matter.
Mentions: SSR
Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic Focus
Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference
41 Biggest Movers From Yesterday
Gainers BioNTech SE (NASDAQ: BNTX) shares jumped 26.8% to close at $20.64 on Tuesday. Biogen, Inc. (NASDAQ: BIIB) shares climbed 26.1% to close at $281.87 on Tuesday after the...
Cesca forms JV to commercialize cell processing platform; shares up 5%
Cesca Therapeutics (KOOL +5.4%) is up up below-average on the heels of its announced joint venture with stem cell bank operator HealthBanks Biotech (USA) to commercialize CAR-TXpress, its cell
25 Stocks Moving In Tuesday's Mid-Day Session
Gainers Biogen, Inc. (NASDAQ: BIIB) shares shot up 38.49% to $309.53 after the company announced that it intended to file a BLA for its early Alzheimer’s treatment,...
Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Services
Cesca Therapeutics To Present At The 2019 Bio Investor Forum
Top Ranked Momentum Stocks to Buy for October 9th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 9th
Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution Fee
Study says buying a winning stock is easy: Just find a cool ticker symbol
Choosing stocks with cute tickers like those has proven to be a profitable strategy over the previous 12 years.
ThermoGenesis Reports Performance Evaluations of X-Series® Cell Processing Devices
Small Caps Win in September: 5 Best ETFs & Stocks
We highlight five small-cap ETFs and stocks that have outperformed in September. These could be excellent plays for investors should the same trends prevail.
Healthcare and Technology names dominate midday movers
Gainers: Interlink Electronics (OTCPK:LINK) +37%. Avadel Pharmaceuticals plc (NASDAQ:AVDL) +33%. Arotech Corporation (NASDAQ:ARTX) +31%. Plus Therapeutics (NASDAQ:PSTV) +25%. Cesca Therapeutics (NASDA
Plus Therapeutics leads healthcare gainers; Akcea Therapeutics leads the losers
Gainers: Plus Therapeutics (NASDAQ:PSTV) +43%. Avadel Pharmaceuticals (NASDAQ:AVDL) +25%. Cesca Therapeutics (NASDAQ:KOOL) +18%. Dova Pharmaceuticals (NASDAQ:DOVA) +14%. Checkpoint Therapeutics (NASDA
Accelerate Diagnostics (AXDX) Jumps: Stock Rises 9.4%
Accelerate Diagnostics (AXDX) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Mentions: AXDX
Mallinckrodt leads healthcare gainers; Cesca Therapeutics among losers
Gainers: Mallinckrodt (NYSE:MNK) +50%. InspireMD (NYSEMKT:NSPR) +26%. Endo International (NASDAQ:ENDP) +22%. Mesoblast MESO +16%. Adaptimmune Therapeutics (NASDAQ:ADAP) +16%.Losers: Emmaus Life Scienc
ACAD, FSLY, MDLA and PAYS among midday movers
Gainers: ACADIA Pharmaceuticals (NASDAQ:ACAD) +60%. Changyou.com Limited (NASDAQ:CYOU) +49%. Key Energy Services (NYSE:KEG) +29%. Cesca Therapeutics (NASDAQ:KOOL) +25%. Hovnanian Enterprises (NYSE:HOV
Healthcare - Top 5 Gainers / Losers
Gainers: ACADIA Pharmaceuticals (NASDAQ:ACAD) +64%. Cesca Therapeutics (NASDAQ:KOOL) +30%. Sintx Technologies (NASDAQ:SINT) +13%. InMode (NASDAQ:INMD) +13%. InspireMD (NYSEMKT:NSPR) +11%.Losers: Neuro
Cesca Therapeutics up 11% premarket on X-Series products deal
Cesca Therapeutics (NASDAQ:KOOL) and ThermoGenesis, its wholly owned device subsidiary (the "Company") has signed an exclusive, global distribution agreement in which the Company will supply